we offer
t-705 (favipiravir) is an antiviral drug that selectively inhibits the rna-dependent rna polymerase of influenza virus. it is phosphoribosylated by cellular enzymes to its active form, favipiravir-ribofuranosyl-5'-triphosphate (rtp). favipiravir is active against a broad range of influenza viruses, including a(h1n1)pdm09, a(h5n1) and the recently emerged a(h7n9) avian virus. it also inhibits influenza strains resistant to current antiviral drugs, and shows a synergistic effect in combination with oseltamivir, thereby expanding influenza treatment options. recently, t-705 has been shown to give 100% protection against aerosol ebola virus e718 infection in immune-deficient mice as well as inhibiting ebola virus infection in cell culture. it has been shown to inhibit sars-cov-2 in vitro.
usage: for research use only! not for use in humans.
we offer
t-705 (favipiravir) is an antiviral drug that selectively inhibits the rna-dependent rna polymerase of influenza virus. it is phosphoribosylated by cellular enzymes to its active form, favipiravir-ribofuranosyl-5'-triphosphate (rtp). favipiravir is active against a broad range of influenza viruses, including a(h1n1)pdm09, a(h5n1) and the recently emerged a(h7n9) avian virus. it also inhibits influenza strains resistant to current antiviral drugs, and shows a synergistic effect in combination with oseltamivir, thereby expanding influenza treatment options. recently, t-705 has been shown to give 100% protection against aerosol ebola virus e718 infection in immune-deficient mice as well as inhibiting ebola virus infection in cell culture. it has been shown to inhibit sars-cov-2 in vitro.
usage: for research use only! not for use in humans.